what is semaglutide approved for New Weight Loss Medication Wegovy™ by the FDA US FDA approves weight loss

However, there is a gap in knowledge as to understanding whether once weekly semaglutide would lead to reductions in symptoms and physical limitations and to improved exercise function, in addition to weight loss, in patients with heart failure with preserved ejection fraction and obesity

And these arent experimental drugs, for what its worth

Your healthcare provider will: Monitor your progress Adjust dosing as needed Help manage any side effects Provide guidance on lifestyle modifications Ensure safe and effective use of the medication Conclusion Both Ozempic and Wegovy can be effective tools for weight management when used appropriately under medical supervision

JAMA 2025;333:113-4